Minimally invasive treatments for thyroid cancer
Official title: Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma
Run by European Institute of Oncology · NCT06333587 · Data updated 2026-11-12
This study is testing whether less invasive treatments for small thyroid cancers can safely replace surgery and improve patients' quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 270 (estimated) |
| Sponsor | European Institute of Oncology Academic / other |
| Locations | 1 site (Milan) |
| Status | Recruiting |
| Started | October 10, 2022 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2035 |
| Registry record updated | March 27, 2024 |
| Trial ID | NCT06333587 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years with a cytologically proven diagnosis of Papillary Thyroid Microcarcinoma suitable for minimally invasive treatments.
✕Probably not a fit
Patients with tumors larger than 1 cm or those with other types of thyroid cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on the use of minimally invasive treatments, specifically image-guided thermal ablations, as an alternative to surgery for patients diagnosed with Papillary Thyroid Microcarcinoma (PTMC). It aims to establish a prospective registry to validate the safety and efficacy of these treatments while collecting long-term results from a large cohort of patients. The approach is designed to minimize complications and improve quality of life by precisely targeting the tumor while sparing surrounding thyroid tissue.
Why it matters
Potential benefit: If successful, this could provide a less invasive treatment option for patients with Papillary Thyroid Microcarcinoma, leading to fewer complications and improved quality of life.
How similar studies have gone: Other studies have shown promising results with similar minimally invasive approaches, indicating potential for success in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \> 18years * Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT. * Written informed consent must be signed and dated by the patient and the investigator prior to inclusion. * Patients must be accessible for follow-up Exclusion Criteria: * Tumors \> 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders * Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study
Where it's running
-
European Institute of Oncology
Milan, Italy Recruiting
Study contacts
- Principal investigator: Giovanni Mauri — European Institute of Oncology
- Study coordinator: Giovanni Mauri
- Email: giovanni.mauri@ieo.it
- Phone: +390294372691
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Microwave ablation for papillary thyroid microcarcinoma monitored with contrast-enhanced ultrasound and genetic testing
This project will try microwave ablation guided by contrast-enhanced ultrasound and an 88-gene panel in adults with low-risk papillary thyroid microcarcinoma to see if it controls the tumor while preserving thyroid function.
-
Radiofrequency Ablation for Papillary Thyroid Microcarcinoma
This study tests if a less invasive treatment called Radiofrequency Ablation can safely help people with small thyroid cancers who can’t or don’t want to have surgery.
-
Monitoring small thyroid cancers without immediate surgery
This study tests whether watching small thyroid cancers closely instead of doing surgery right away is a safe option for patients and looks at how this choice affects their quality of life and anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.